These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16671192)

  • 21. [Are there any clinical evaluations confirming higher incidence of skin cancers as a result of pimecrolimus therapy?].
    Barańjska-Rybak W; Nowicki R; Sokołowska-Wojdyło M; Roszkiewicz J
    Pol Merkur Lekarski; 2008 Sep; 25(147):284-7. PubMed ID: 19112851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Science, marketing and pharmacovigilance: the example of topical calcineurin inhibitors].
    Paul C
    Ann Dermatol Venereol; 2007 Nov; 134(11):817-21. PubMed ID: 18033059
    [No Abstract]   [Full Text] [Related]  

  • 23. [Topical calcineurin inhibitors in atopic eczema -- pro].
    Wollenberg A
    Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1614. PubMed ID: 16823713
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus.
    Gradman J; Wolthers OD
    Acta Paediatr; 2007 Aug; 96(8):1233-7. PubMed ID: 17590198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin cream do's and don'ts for eczema.
    Johns Hopkins Med Lett Health After 50; 2014 Apr; 26(2):6. PubMed ID: 24872995
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
    Ring J; Abraham A; de Cuyper C; Kim K; Langeland T; Parra V; Pigatto P; Reunala T; Szczepanski R; Möhrenschlager M; Bräutigam M; Rossi AB; Meents-Kopecky E; Schneider D
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema.
    Schurmeyer-Horst F; Luger TA; Bohm M
    Dermatology; 2007; 214(1):99-100. PubMed ID: 17191058
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticosteroid contact allergy--the importance of late readings and testing with corticosteroids used by the patients.
    Isaksson M
    Contact Dermatitis; 2007 Jan; 56(1):56-7. PubMed ID: 17177720
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergic contact dermatitis from oleyl alcohol in Elidel cream.
    Andersen KE; Broesby-Olsen S
    Contact Dermatitis; 2006 Dec; 55(6):354-6. PubMed ID: 17101011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical calcineurin inhibitors revisited.
    Qureshi A; Fischer MA
    Arch Dermatol; 2007 Apr; 143(4):545-6. PubMed ID: 17438195
    [No Abstract]   [Full Text] [Related]  

  • 31. Injectable Drug Approved for Moderate-to-Severe Eczema.
    Aschenbrenner DS
    Am J Nurs; 2017 Jul; 117(7):23. PubMed ID: 28644285
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical calcineurin inhibitors labeling: putting the "box" in perspective.
    Stern RS
    Arch Dermatol; 2006 Sep; 142(9):1233-5. PubMed ID: 16983018
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
    Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
    Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General principles of eczema therapy].
    Harnack K
    Z Arztl Fortbild (Jena); 1990; 84(23):1184-6. PubMed ID: 2085017
    [No Abstract]   [Full Text] [Related]  

  • 35. Black box warning for topical calcineurin inhibitors and the death of common sense.
    Fleischer AB
    Dermatol Online J; 2006 Oct; 12(6):2. PubMed ID: 17083882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo.
    Hui-Lan Y; Xiao-Yan H; Jian-Yong F; Zong-Rong L
    Pediatr Dermatol; 2009; 26(3):354-6. PubMed ID: 19706108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Possible use of diucifon in true eczema].
    Kubanova AA; Vadil'eva LL; Petrova IV; Leshchenko GM
    Vestn Dermatol Venerol; 1983 Dec; (12):24-6. PubMed ID: 6369823
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
    Zuberbier T; Bräutigam M
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizophreniform Psychosis During Treatment With Alitretinoin.
    Bumb JM; Solojenkina X; Zink M
    J Clin Psychopharmacol; 2015 Oct; 35(5):612. PubMed ID: 26252440
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance in phlebology of a spray dermatologic cream].
    Pelletier J
    Phlebologie; 1967; 20(1):85-6. PubMed ID: 6060673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.